Ankita Srivastava

Dr. Ankita Srivastava

Thomas Jefferson University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
ANARATHI NAIR
ARATHI NAIR
SCSushmita Chakraborty
Sushmita Chakraborty
LBLate Anirban Banerji
Late Anirban Banerji
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
CNCharudutta Navare
Charudutta Navare
BSBhaskar Saha
Bhaskar Saha
Background: Ras are small cellular GTPases which regulate diverse cellular processes. It has three isoforms: H-Ras, K-Ras, and N-Ras. Owing to the N-terminus (1–165 residues) sequence homology these isoforms were thought to be functionally redundant. However, only K-Ras-deficient mice but not H-Ras- and N-Ras-deficient mice show embryonic lethality. Similarly, mutations in a given Ras isoform are associated with a particular type of cancer. Moreover, we have previously reported that Ras isoforms perform unique functions inLeishmania majorinfection. Thus, Ras isoforms are implicated to have signaling and functional specificity but the mechanism remains to be elucidated.Result: Using CD40 as a model receptor, we showed that depending on the strength of signaling, specific Ras isoforms are activated. Weak CD40 signal activates N-Ras, whereas strong signal activates H-Ras and K-Ras. Additionally, we showed that suppression of N-Ras expression reduced CD40-induced extracellular signal–regulated kinase-1/2 (ERK-1/2) activation and Interleukin (IL)-10 production; whereas suppression of H-Ras or K-Ras reduced CD40-induced p38 mitogen-activated protein kinase (p38MAPK) activation and IL-12 production. Furthermore, we showed that Ras isoforms have activator (GEF) specificity as weak CD40 signal-activated N-Ras requires Sos-1/2 whereas strong CD40 signal-activated H-Ras/K-Ras requires Ras-GRP as the guanine-nucleotide exchange factor (GEF) inducing ERK-1/2- or p38MAPK-mediated IL-10 or IL-12 productions, respectively, in macrophages. Silencing of syk reduced CD40-induced N-Ras activation but silencing of lyn inhibited H-Ras and K-Ras activation. In CD40 signaling, Ras isoforms also showed effector specificity; while H-Ras and K-Ras showed specificity for phosphatidyl inositol-3 kinase activation at high dose of CD40 stimulation, N-Ras primarily associated with Raf-1 at low dose of CD40 stimulation. Moreover, fractal analysis showed that functional site surface roughness for H-Ras (SurfaceFD = 2.39) and K-Ras (SurfaceFD = 2.39) are similar but significantly different from N-Ras (SurfaceFD = 2.25).Conclusion: The activator and effector specificities of Ras isoforms in CD40 signaling indicated their differential involvement in CD40 pathway and in maintaining the reciprocity. Our observations reveal Ras-regulated signaling outcome and its potential for developing Ras isoform-targeted immunotherapy and prophylaxis.Graphical

1 March 2024 in Physiological Genomics
Verified
Journal Article
Open access
AMAlison Moss
Alison Moss
LKLakshmi Kuttippurathu
Lakshmi Kuttippurathu
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
JSJames S. Schwaber
James S. Schwaber
Rajanikanth VadigepalliRajanikanth Vadigepalli
Rajanikanth Vadigepalli
Hypertension is a major disease and is the primary risk factor for cardiovascular complications and stroke. The gene expression changes in the central nervous system circuits driving hypertension are understudied. Here, we show that coordinated and region-specific gene expression changes occur in the brainstem autonomic circuits over time during the development of a high blood pressure phenotype in a rat model of human essential hypertension.

18 September 2025 in Frontiers in Network Physiology
Verified
Journal Article
Open access
PDF file
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
Santosh Kumar YadavSantosh Kumar Yadav
Santosh Kumar Yadav
Introduction The landscape of personal health monitoring is rapidly transforming, driven by advances in wearable technology. These devices, designed to be worn comfortably on the body, can capture real-time physiological data often difficult to obtain in traditional clinical settings. What began as a simple device for activity trackers for walking steps, heart rate, and blood oxygen saturation has evolved to play a crucial role in monitoring more complex physiological parameters critical for chronic disease management and preventative health. The integration of artificial intelligence (AI) is further expanding the potential of wearable devices, enabling deeper analysis and predictive modeling of the recorded data. As AI-driven models become more refined, wearable technologies are poised to transform health monitoring, enabling early disease detection and personalized interventions. In many ways, we are at a pivotal moment in digital health, well-positioned to reimagine how healthcare is delivered, monitored, and personalized. This editorial discusses emerging clinical applications of wearable technologies across different life stages in patient care, the key limitations, and prospects in the rapidly advancing field. These include sleep monitoring in children, menstrual cycle tracking in reproductive-aged females, and cardiovascular monitoring in Parkinson's disease. Collectively, these studies highlight how continuous, real-time physiological data can uncover underlying subtle biological patterns and inform tailored interventions. Wearables in Pediatric Sleep Monitoring In children, particularly those with sensory sensitivities, the settling-down period (time between the end of bedtime routine and sleep onset) can be challenging. In a recent study, Hartman and colleagues investigated how wearable devices recorded data combined with machine learning models could help characterize the differences in the settling-down period in children with and without sensory sensitivities (SS/NSS) (Kocanaogullari, Akcakaya, Bendixen, Soehner, & Hartman, 2025). The study involved continuous two-week actigraphy data (measurement of rest and activity cycles) collection using the ActiGraph GT9X device worn on children with (n=17) and without (n=18) sensory sensitivities. Combining caregiver reports and the motor activity actigraphy data, the authors selected seven features and trained a machine learning model to distinguish between the SS and NSS groups with a high accuracy (84.1%), specificity (82.7%), and sensitivity (84.4%) (Figure 1A). This study highlights the potential of wearables in pediatric behavioral health and opens new avenues for personalized pediatric behavior interventions. However, limitations such as small cohort size, lack of diversity in the study groups, variability in wearable device placement, and reliance on subjective caregiver reports highlight the need to use larger and diverse sample cohorts, confirm observed activity differences, and apply them in intervention studies for children with sleep difficulties. Future studies should involve a larger and more diverse sample cohort and incorporate additional physiological parameters, e.g., heart rate variability and skin temperature, to provide a more comprehensive understanding of the physiological state during the settling-down period. Wearables in Advancing Reproductive Health through Cycle Tracking In reproductive-aged females, wearable technologies offer novel opportunities to track the menstrual cycle and optimize menstrual health management. Nasseri's group used a wearable device to understand female reproductive physiology and investigated menstrual cycle dynamics (Sides et al., 2023). In this study, physiological data were recorded using wearable sensors (Empatica E4 wristband) from healthy female individuals (n= 15; 18–40 years old) across 39 cycles (31 ovulating, 8 non-ovulating). The collected data included mean temperature, heart rate, inter-beat interval, and the mean tonic component of Electrodermal Activity (EDA). The authors used circular statistics to select key features for time series forecasting using the Autoregressive Integrated Moving Average (ARIMA) algorithm. This approach accurately identified and predicted menstrual cycle phases, distinguishing between ovulating and non-ovulating cycles (Figure 1B). The study contributes significantly to precise menstrual health management and personalised medical interventions based on distinct physiological patterns recorded by a wearable device. For instance, a reproductive-aged female undergoing medication while trying to conceive could monitor and adjust dosages in consultation with a physician according to their menstrual phase. Similarly, females with health issues linked to a specific menstrual phase, such as catamenial epilepsy, may benefit by adjusting the anti-seizure medication dosage based on their ovulatory status. The study has limitations, including a small sample size, data variability based on the wristband positioning, and the absence of blood hormonal levels to detect ovulation. Nonetheless, accurately identifying and predicting menstrual phases and distinguishing ovulating from non-ovulating cycles holds immense promise for precise menstrual health management and individualized medical interventions. Wearables in Cardiovascular Autonomic Monitoring in Neurodegenerative Disease In older adults with neurodegenerative conditions, managing autonomic dysfunction is particularly challenging. Berkebile`s group evaluated the feasibility of a wearable chest patch to monitor cardiovascular autonomic (CVA) function in Parkinson's disease (PD) patients undergoing levodopa treatment (Kehnemouyi, Coleman, & Tass, 2024). Levodopa, the primary medication for motor symptoms in Parkinson's disease and multiple system atrophy (MSA), can exacerbate cardiovascular autonomic (CVA) dysfunction due to its potential hypotensive effect. Monitoring CVA function is...

1 October 2025 in Physiological Genomics
Verified
Journal Article
Closed access
AMAlison Moss
Alison Moss
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
LKLakshmi Kuttippurathu
Lakshmi Kuttippurathu
JSJames S. Schwaber
James S. Schwaber
Rajanikanth VadigepalliRajanikanth Vadigepalli
Rajanikanth Vadigepalli
Hypertension is the primary risk factor for cardiovascular complications and stroke. The microRNA expression changes in the central nervous system circuits driving hypertension development are understudied. Here, we show that microRNA-mediated regulatory networks are dynamically rewired during the development of high blood pressure phenotype by targeting key signaling pathways, neuronal plasticity, and inflammatory processes in a female rat model of human essential hypertension.

24 September 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
USUddipan Sarma
Uddipan Sarma
MMMoitrayee Maiti
Moitrayee Maiti
ANARATHI NAIR
ARATHI NAIR
SBSagar Bhadange
Sagar Bhadange
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
DMDebasri Mukherjee
Debasri Mukherjee
IFNγ and IL10 pathways elicit functionally opposing cell fates, however, these two stimuli activate common transcription factors like STAT1 and STAT3 (S/1/3). How the two stimuli regulate the dynamics of S/1/3 activation remains less understood. Here, we experimentally measured the signaling dynamics of S/1/3 in response to IFNγ and IL10 and found that STAT3, in particular, exhibits a bell-shaped response to both stimuli with maximal activation in an intermediate dose. We built a mathematical model, which quantitatively captured the S/1/3 dynamics and by model analysis, we identified the primary regulators controlling the bell-shaped STAT3 responses in both pathways. As the STATs are activated in response to both stimuli, in a scenario when cells are subjected to co-stimulation of IFNγ and IL10, an interpathway competition to activate the common substrate is plausible. Additionally, a strong transcriptional induction of SOCS1 (a negative regulator of IFNγ pathway) was observed upon IL10 stimulation, suggesting that IL10 pathway can potentially inhibit the IFNγ pathway via SOCS1 induction. To quantitatively understand the S/1/3 responses to co-stimulation we next simulated the same which predicted STAT3 activation and SOCS1 induction dynamics would robustly remain IL10 driven. Subsequent experiments validated the model predictions. Further, the model analysis identified the primary regulators controlling the robustness of IL10-STAT3 axis in co-stimulation. Together, our data-driven model quantitatively captured the dynamics of the STATs in response to both pro (IFNγ) and anti (IL10)-inflammatory stimuli and identifies distinct regulatory elements controlling STAT3 signaling in individual and co-stimulation conditions.

4 August 2022 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
SOSean J. O'Sullivan
Sean J. O'Sullivan
Ankita SrivastavaAnkita Srivastava
Ankita Srivastava
Rajanikanth VadigepalliRajanikanth Vadigepalli
Rajanikanth Vadigepalli
JSJames S. Schwaber
James S. Schwaber
Increasing rates of addiction behavior have motivated mental health researchers and clinicians alike to understand antireward and recovery. This shift away from reward and commencement necessitates novel perspectives, paradigms, and hypotheses along with an expansion of the methods applied to investigate addiction. Here, we provide an example: A systems biology approach to investigate antireward that combines laser capture microdissection (LCM) and high-throughput microfluidic reverse transcription quantitative polymerase chain reactions (RT-qPCR). Gene expression network dynamics were measured and a key driver of neurovisceral dysregulation in alcohol and opioid withdrawal, neuroinflammation, was identified. This combination of technologies provides anatomic and phenotypic specificity at single-cell resolution with high-throughput sensitivity and specific gene expression measures yielding both hypothesis-generating datasets and mechanistic possibilities that generate opportunities for novel insights and treatments.